Key statistics
On Thursday, Hillevax Inc (HLVX:NSQ) closed at 1.82, 17.42% above the 52 week low of 1.55 set on Jul 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.81 |
---|---|
High | 1.82 |
Low | 1.78 |
Bid | 1.82 |
Offer | 1.85 |
Previous close | 1.79 |
Average volume | 140.93k |
---|---|
Shares outstanding | 49.81m |
Free float | 40.46m |
P/E (TTM) | -- |
Market cap | 90.65m USD |
EPS (TTM) | -3.09 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
- HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
- HilleVax Announces Reduction in Force
- HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
- HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
- HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
- HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
- HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
- HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
- HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼